Scientific articles 10 Oct 2026 Rethinking Clinical Trial Design to Accelerate Therapeutics for Arboviral Epidemics Open Forum Infectious Diseases
News 9 Oct 2026 DNDi 2026 Projects of the Year recognize teams and partners for their work to advance an open-science antiviral for future coronavirus pandemics and a single-dose treatment for sleeping sickness
Scientific articles 9 Oct 2026 A Perspective on Biomarkers, Candidates for Surrogate End Points to Accelerate Successful Development of New Antiparasitic Agents for the Treatment of Chronic Chagas Disease ACS Infectious Diseases
Press releases 6 Oct 2026 Ghana’s KNUST and DNDi partner to accelerate drug discovery for neglected diseases in Africa
Scientific articles 5 Oct 2026 Winning the endgame against sleeping sickness: Efficacy profiling of acoziborole against African trypanosomes with the focus on Trypanosoma brucei rhodesiense PLoS Neglected Tropical Diseases
Statements 25 Sep 2026 DNDi intervention at the UN High-Level Meeting on Pandemic Prevention, Preparedness, and Response at the 81st UN General Assembly
In the media 24 Sep 2026 De Etiopía a Lleida: la desigualdad mata tanto como los virus durante una pandemia El País
Scientific articles 22 Sep 2026 Efficacy and safety of alternative benznidazole and nifurtimox regimens for adults with chronic Trypanosoma cruzi infection (TESEO): an open-label, randomised, non-inferiority phase 2b trial The Lancet Infection Diseases
Scientific articles 19 Sep 2026 Thermotherapy compared with intralesional sodium stibogluconate for Leishmania aethiopica cutaneous Leishmaniasis in Ethiopia: A phase II randomized controlled trial BMC Medicine
News 15 Sep 2026 New DNDi report: Implementing Article 9.5 of the WHO Pandemic Agreement – building on current policy and practice for publicly funded R&D
In the media 9 Sep 2026 Des acteurs pharmaceutiques à but non lucratif s’allient pour faire face à la baisse des financements Swissinfo
Scientific articles 1 Sep 2026 Analysis of the therapeutic gap for Trypanosoma cruzi infection in Colombia (2012 – 2022) Memórias do Instituto Oswaldo Cruz
Scientific articles 8 Apr 2021 Film-forming systems for the delivery of DNDI-0690 to treat cutaneous leishmaniasis Pharmaceutics
Scientific articles 6 Apr 2021 New regimens of benznidazole monotherapy and in combination with fosravuconazole for treatment of Chagas disease (BENDITA): A phase 2, double-blind, randomised trial The Lancet Infectious Diseases
Scientific articles 6 Apr 2021 Prediction of parasitological cure in children infected with Trypanosoma cruzi using a novel multiplex serological approach: An observational, retrospective cohort study The Lancet Infectious Diseases
Scientific articles 31 Mar 2021 High variation in immune responses and parasite phenotypes in naturally acquired Trypanosoma cruzi infection in a captive non-human primate breeding colony in Texas, USA PLOS Neglected Tropical Diseases
Scientific articles 30 Mar 2021 “You don’t have a normal life”: Coping with Chagas disease in Los Angeles, California Medical Anthropology
Scientific articles 29 Mar 2021 Serious adverse events following treatment of visceral leishmaniasis: A systematic review and meta-analysis PLOS Neglected Tropical Diseases
Scientific articles 24 Mar 2021 Safety, tolerability, and pharmacokinetics of emodepside, a potential novel treatment for onchocerciasis (river blindness), in healthy male subjects British Journal of Clinical Pharmacology
Scientific articles 22 Mar 2021 Guidelines should not pool evidence from uncomplicated and severe COVID-19 The Lancet
Scientific articles 17 Mar 2021 A systematic review and an individual patient data meta-analysis of ivermectin use in children weighing less than fifteen kilograms: Is it time to reconsider the current contraindication? PLOS Neglected Tropical Diseases
Scientific articles 2 Mar 2021 Low antileishmanial drug exposure in HIV-positive visceral leishmaniasis patients on antiretrovirals: An Ethiopian cohort study Journal of Antimicrobial Chemotherapy
Scientific articles 22 Feb 2021 2-aminobenzimidazoles for leishmaniasis: From initial hit discovery to in vivo profiling PLOS Neglected Tropical Diseases
Scientific articles 13 Feb 2021 Blood parasite load as an early marker to predict treatment response in visceral leishmaniasis in Eastern Africa Clinical Infectious Diseases
Scientific articles 8 Feb 2021 Drug-drug interaction study of benznidazole and E1224 in healthy male volunteers Antimicrobial Agents and Chemotherapy
Scientific articles 23 Jan 2021 The challenges of recruitment in clinical trials in developing countries: the Mycetoma Research Centre experience Transactions RSTMH
Scientific articles 21 Jan 2021 Collaborative virtual screening to elaborate an imidazo[1,2-a]pyridine hit series for visceral leishmaniasis RSC Medicinal Chemistry